您当前的位置:
首页 >
文章列表页 >
Construction of the pharmacoeconomic evaluation system of Chinese patent medicine in the prevention and treatment of major chronic diseases
更新时间:2022-11-09
    • Construction of the pharmacoeconomic evaluation system of Chinese patent medicine in the prevention and treatment of major chronic diseases

    • China Pharmacy   Vol. 33, Issue 17, (2022)
    • Published:2022

    扫 描 看 全 文

  • XU Gan, LUO Weihua, WANG Yuwei, et al. Construction of the pharmacoeconomic evaluation system of Chinese patent medicine in the prevention and treatment of major chronic diseases. [J]. China Pharmacy 33(17).(2022) DOI:

  •  
  •  

0

Views

1

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Clinical comprehensive evaluation for Chinese patent medicine based on evidence-based medicine and pharma- coeconomic model
Pharmacoeconomics of ivabradine in the treatment of CHF in the context of “Quadruple Therapy”
Study on pharmacoeconomic evaluation of vericiguat in the treatment of heart failure with reduced ejection fraction
Pharmacoeconomic evaluation of sugemalimab consolidation therapy for stage Ⅲ non-small cell lung cancer
Pharmacoeconomic evaluation of serplulimab combined with chemotherapy regimens for the first-line treatment of extensive-stage small-cell lung cancer

Related Author

TANG Xianshuai
ZHENG Lei
ZHANG Mingzhu
GUAN Yuyao
YANG Jing
CHEN Congling
WU Han
ZHOU Jie

Related Institution

Dept. of Pharmacy, Nanjing Drum Tower Hospital
School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
Dept. of Cardiology, Nanjing Drum Tower Hospital
Dept. of Pharmacy, the Affiliated Hospital of North Medical College, Sichuan Nanchong
School of Pharmaceutical Sciences, Peking University
0